Market need Epilepsy management and remote titration represent a clear clinical and scheduling bottleneck; target hospitals and health systems looking to reduce medication titration cycles and seizure burden through device-agnostic monitoring.

Technology leverage Platform already integrates cloud and data infrastructure (AWS, Redshift, email services) with wearable data for remote patient monitoring; prioritize buyers seeking scalable, interoperable digital health solutions.

Growth potential Long-term vision to expand to other neurological and behavioral conditions provides a pathway for expanding contracts within multi-specialty hospitals and neuroscience centers.

Funding signals Recent grants and recognition as a Digital Health Awards quarterfinalist indicate credibility with potential customers and investors; leverage for partner and pilot program outreach.

Financial opportunity Revenue range and modest funding suggest a mid-stage company open to pilot programs, co-development partnerships, and early-adopter health systems seeking innovative seizure management tools.